| Title : A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine - Francis_2019_Antimicrob.Agents.Chemother_63_e01964 |
| Author(s) : Francis J , Zvada SP , Denti P , Hatherill M , Charalambous S , Mungofa S , Dawson R , Dorman S , Gupte N , Wiesner L , Jindani A , Harrison TS , Olagunju A , Egan D , Owen A , McIlleron HM |
| Ref : Antimicrobial Agents & Chemotherapy , 63 : , 2019 |
| Abstract : Francis_2019_Antimicrob.Agents.Chemother_63_e01964 |
| ESTHER : Francis_2019_Antimicrob.Agents.Chemother_63_e01964 |
| PubMedSearch : Francis_2019_Antimicrob.Agents.Chemother_63_e01964 |
| PubMedID: 30670438 |
| Gene_locus related to this paper: human-AADAC |
| Gene_locus related to this paper: human-AADAC |
Francis J, Zvada SP, Denti P, Hatherill M, Charalambous S, Mungofa S, Dawson R, Dorman S, Gupte N, Wiesner L, Jindani A, Harrison TS, Olagunju A, Egan D, Owen A, McIlleron HM (2019)
A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine
Antimicrobial Agents & Chemotherapy
63 :
Francis J, Zvada SP, Denti P, Hatherill M, Charalambous S, Mungofa S, Dawson R, Dorman S, Gupte N, Wiesner L, Jindani A, Harrison TS, Olagunju A, Egan D, Owen A, McIlleron HM (2019)
Antimicrobial Agents & Chemotherapy
63 :